###begin article-title 0
Nerve growth factor modulates toll-like receptor (TLR) 4 and 9 expression in cultured primary VKC conjunctival epithelial cells
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
To investigate if nerve growth factor (NGF) might modulate toll-like receptor (TLR) 4 and 9 expression in primary cultures of vernal keratoconjunctivitis (VKC)-derived conjunctival epithelial cells (VKC-ECs).
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
Primary cultures of ECs were established from VKC (n=7) and healthy-control (n=5) conjunctival specimens. Primary untouched and short-term NGF-exposed VKC-ECs were analyzed for molecular (relative real-time PCR) and biochemical (confocal and fluorescence-activated cell sorting analysis of TLR4 and TLR9 expression. Data were compared to their untreated as well as stimulated healthy-control counterparts. Conditioned media were analyzed for interferon (IFN)-gamma, interleukin (IL)-4, IL-10, and IL-12 p40 secretion.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
Primary untouched VKC-ECs showed TLR4 increase and TLR9 decrease compared to their healthy-control counterparts. NGF exposure resulted in a strong upregulation of TLR4 and a moderate upregulation of TLR9 in few passages VKC-ECs. Both TLR4 and TLR9 upregulation occurred in a dose-dependent fashion and were supported by biochemical analysis. NGF triggered a dose-response release of IL-10 in VKC-ECs conditioned media, an effect not detected for IL-4, IL-12 p40, and IFN-gamma.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
Our data indicate that NGF is able to induce TLR4/TLR9 overexpression in VKC-ECs. These cells exhibited poor IL-4, IL-12 p40, and IFN-gamma responses to NGF, while a significant IL-10 decreased secretion was detected. The different NGF-induced TLR response between VKC and healthy-control conjunctival ECs as well as the different cytokine response might reflect a different pattern of cell activation according to the state of VKC.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 704 708 704 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 717 720 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
Vernal keratoconjunctivitis (VKC) is a childhood, chronic, allergic eye disease, with a multifactorial pathogenesis [1]. The immune reaction is characterized by T helper subtype 2 lymphocytes cells, eosinophils, mast cells, and fibroblast infiltration and/or activation, together with a complex network of soluble mediators, which can lead to corneal complications [1-3]. Cytokines, growth factors, neuropeptides and other soluble mediators are increased in tears and active VKC and involve conjunctival epithelial cells (ECs) and fibroblasts in the inflammatory reaction [4,5]. Among these factors, nerve growth factor (NGF) plays pleiotropic effects on ECs, fibroblast and immune cells [6-8]. NGF, trkANGFR, and p75NTR are widely expressed in the healthy ocular surface and significantly change under pathological states [9-11]. NGF is affected in VKC blood and tarsal conjunctiva, implying a NGF possibility to modulate ocular inflammation and epithelial activities [11,12].
###end p 10
###begin p 11
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 954 956 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
Conjunctival ECs play a significant pro-inflammatory role in VKC by participating in the local immune reaction throughout the synthesis of cytokines known to promote inflammation and expression of molecules (intracellular adhesion molecule-1) able to recruit inflammatory cells [13]. Being the first line of defense, ECs express a class of transmembrane receptors named the toll-like receptors (TLRs) [13,14]. TLRs activate the innate (host) immune reaction, launch the adaptive immune response, and modulate the Th1/Th2 cell balance in several allergic/autoimmune disorders [15-17]. In the ocular surface, the widespread TLR distribution offers a quick and selective response to pathogens [18,19]. TLR expression/function is highly dynamic and tightly regulated in response to encountered bacterial stimuli [15]. TLR variation during bacterial/viral infections as well as allergic/autoimmune inflammation highlights a more complex functional mechanism [18]. We demonstrated a TLR4 transcript upregulation and a TLR9 transcript downregulation in VKC-inflamed conjunctival epithelium, suggesting a TLR contribution in the pathogenesis of the disease [20].
###end p 11
###begin p 12
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
Some recent findings propose an NGF contribution in the innate and adaptive immune responses [21,22]. Herein, primary cultures of VKC conjunctival ECs were checked for TLR4/TLR9 expression and then exposed to exogenous NGF to evaluate TLR4/TLR9 changes at either molecular and biochemical levels as well as cytokine release (interferon [IFN]-gamma, interleukin [IL]-4, IL-10, and IL-12 p40) in the conditioned media.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Tissue sampling and establishment of primary cultures
###end title 14
###begin p 15
###xml 1189 1190 1180 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1231 1233 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1234 1236 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1342 1343 1333 1334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1366 1369 1357 1360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-2</sub>
###xml 1462 1464 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">Patients</span>
###xml 626 634 <span type="species:ncbi:9606">patients</span>
###xml 698 709 <span type="species:ncbi:9606">participant</span>
###xml 719 727 <span type="species:ncbi:9606">patients</span>
###xml 877 882 <span type="species:ncbi:9606">human</span>
###xml 1566 1571 <span type="species:ncbi:10090">mouse</span>
###xml 1577 1582 <span type="species:ncbi:9606">human</span>
A total of 7 patients with active VKC (5 male/2 female, mean age 15.71+/-5.59) and 5 sex/age-matched healthy-control patients, who underwent minor surgery, were included in the study. Active VKC diagnosis was based on clinical presentation, complete ophthalmic examination and basal histology (eosinophils in conjunctival scraping). Patients had recurrent itching, redness, photophobia, tearing in early spring associated with mild to severe cobblestone-like appearance of the upper tarsal conjunctiva, mucous discharge, and epithelial keratopathy. A conjunctival biopsy was obtained from the upper tarsal conjunctiva of both patients and controls. A signed consent was obtained from each informed participant (parents/patients). All protocols adhered to the tenets of the Declaration of Helsinki and the ARVO Statement in Ophthalmic and Vision Research for research involving human subjects and were performed according to the Intramural committement. Specimens were cut into several pieces, put as explants in collagen-coated 24-well plates and left to attach for 10 min, before adding serum-free media (dF12 containing 100 U/ml penicillin and 100 mug/ml streptomycin; 37 degreesC, 5% CO2 in air), to favor the migration of ECs [23-25]. Cells outgrowing from explants (after 1 week of culturing) were maintained for an additional 10 days (P0) and split/expanded (P1-2) according to a standardized enzymatic-harvest protocol (DispaseII from ICN, Milan, Italy) [25]. Conjunctival ECs were screened for the selective expression of the defining marker cytokeratin 19 (mouse anti-human CK19; 1/100, Dako Corp., Carpinteria, CA) and the absence of the fibroblast contaminants Thy-1/alpha-Smooth Muscle Actin for Fibroblasts (FB)/myofibroblasts (myoFBs; Dako). In case of mycoplasm contamination (Hoechst staining), the cells were one passage-treated with Mycoplasm Removal Agent (5 mug/ml; ICN). All molecular and biochemical reagents were purchased from ICN, SERVA (Weidelberg, Germany), and Euroclone (Milan, Italy), while sterile tissue culture plasticware were from Nunc (Roskilde, Denmark).
###end p 15
###begin title 16
NGF dose-response experiments
###end title 16
###begin p 17
###xml 14 17 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-2</sub>
###xml 114 120 <span type="species:ncbi:10090">murine</span>
Few passage (P1-2) ECs were cultured for these studies in order to retain VKC-EC phenotype. The biological active murine 2.5S betaNGF Grade I (herein referred to as NGF; Alomone Labs. Ltd, Jerusalem, Israel) was used for the specific dose-response experiments (1-250 ng/ml). Neutralizing anti-NGF antibodies were from R&D (Minneapolis, MN). After short-term exposure (24 h), monolayers were washed in Hanks' Balanced Sodium Salt (HBSS) and directly used for confocal analysis or enzymatically harvested as single cells before performing molecular (relative real-time PCR) or biochemical (fluorescence-activated cell sorting [FACS]/ enzyme-linked immuno-sorbent assay [ELISA]) analysis. Conditioned media were assayed for cytokine expression. Cells from each specimen were used in independent experiments and not pooled.
###end p 17
###begin title 18
Confocal analysis
###end title 18
###begin p 19
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 485 489 485 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 222 228 <span type="species:ncbi:9913">bovine</span>
###xml 340 346 <span type="species:ncbi:9986">rabbit</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
###xml 411 415 <span type="species:ncbi:9925">goat</span>
###xml 421 426 <span type="species:ncbi:9606">human</span>
###xml 464 469 <span type="species:ncbi:10090">mouse</span>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 494 498 <span type="species:ncbi:9925">goat</span>
###xml 504 509 <span type="species:ncbi:9606">human</span>
Monolayers were post fixed in 4% buffered-paraformaldehyde (PFA; prepared in 1x phosphate-buffered saline [PBS], pH 7.5) and quenched in 50 mM NH4CL before fluorescence staining. A brief blocking/permeabilizing step (0.8% bovine serum albumin [BSA] and 0.3% Triton-X100 in PBS) was performed before the addition of the specific antibodies: rabbit anti-human TLR4 (sc-10741; Santa Cruz Biotech, Santa Cruz, CA), goat anti-human TLR9 (sc-16247; Santa Cruz Biotech), mouse anti-human trkANGFR and goat anti-human p75NTR antibodies (0.5-1 microg/ml; R&D). Specie-specific Cy2/Cy5-conjugated secondary antibodies (Jackson ImmunoResearch Europe Ltd, Suffolk, UK) were used to detect specific binding. The slides were closed using an anti-fading medium (Vectamount; Vector Laboratories, Inc., Burlingame, CA). Irrelevant isotype-matched IgG antibodies (Vector Laboratories, Inc.) were incubated in parallel and used as controls for the channel series acquisitions and related background subtraction. Oil immersion images were acquired by C1 software connected to an E4000 inverted microscope (Nikon, Tokyo, Japan). Figures were assembled in Adobe Photoshop 7.0 (Adobe Systems Inc., San Jose, CA) and minimal adjustments were made to the figure to obtain the best quality.
###end p 19
###begin title 20
Total RNA extraction, cDNA synthesis and relative real-time PCR
###end title 20
###begin p 21
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 210 218 210 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trkA<sup>NGFR</sup></italic>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p75<sup>NTR</sup></italic>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H3</italic>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 360 368 355 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260/280 </sub>
###xml 838 839 817 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 840 842 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 843 845 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 1408 1414 1365 1371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">target</sub>
###xml 1423 1432 1376 1385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">reference</sub>
###xml 1596 1611 1543 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(-&#916;&#916;Ct)</sup>
###xml 1641 1647 1568 1574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sample</sub>
###xml 1656 1666 1579 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calibrator</sub>
###xml 1693 1695 1616 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 524 530 <span type="species:ncbi:10090">Murine</span>
Total RNA was extracted by OMNIzol (Ambion, Milan, Italy) and run for real-time RT-PCR amplification (Opticon2 thermocycler; MJ Research, Watertown, MA) with the gene-specific primers for the human TLR4, TLR9, trkANGFR, p75NTR, GAPDH and H3 genes (MWG, Biotech, Ebersberg, Germany) [8,20,26]. RNA was screened according to the spectrophotometer (ND1000; lambda260/280 >1.8; NanoDrop Technologies, Wilmington, DE) as well as agarose gel size-fractionation analysis. cDNA was synthesized from 3 microg total RNA using Moloney Murine Leukemia Virus (MMLV) reverse transcriptase (IMPROM; Promega, Milan, Italy). For amplification, SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) was used, and 47 cycles were run with denaturation at 94 degreesC/30 s and extension at 75 degreesC/30 s with the specific annealing temperatures [8,20,26]. A 60 degreesC to 95 degreesC melting curve was recorded for each sample/gene. Samples tested negative for DNA contamination, as detected by amplification of total RNA instead of cDNA. Negative controls (without template) and positive controls were produced for each plate run. In pilot experiments, amplicons were purified (Wizard(R) SV Gel and PCR Clean-Up System; Promega) and checked for amplicon identity. Samples were amplified in triplicate, and from these replicates, averages were calculated and expressed as real cycle threshold (Ct; DeltaCt = DeltaCttarget- DeltaCtreference) and reported as normalized DeltaCts+/-SD or as an expression ratio of a normalized target gene (fold changes in log2-expression ratio), according to the formula 2(-DeltaDeltaCt), where DeltaDeltaCt = DeltaCtsample- DeltaCtcalibrator (REST 384-2006 software) [27].
###end p 21
###begin title 22
FACS analysis
###end title 22
###begin p 23
###xml 514 515 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 692 694 692 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 713 715 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1011 1012 1011 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Single cells were processed for membrane/cytoplasm staining (TLR4/TLR9 diluted 1/100; Santa Cruz), according to a standardized protocol, including fixation (3.7% PFA in Hank's Balanced Salt Solution (HBSS) and blocking/permeabilization (3% BSA and 0.3% Triton-X100 in HBSS) treatments. The indirect-immunofluorescence staining was carried out with specific primary antibodies followed by FC/PerCPCy5-coupled, specific, secondary antibodies (Jackson ImmunoResearch) in HBSS containing 0.3% Triton-X100 and 0.01% NaN2. Control fluorescent staining (isotype-matched antibodies from eBiosciences, San Diego, CA) was run in parallel for each set of experiments. Cells were evaluated by FACSCaliburTM using CellQuestProTM software (Becton-Dickinson, San Jose, CA). Logarithmic and linear signals were acquired/analyzed from 5000 gated cells/sample and presented using WinMDI 2.5 software (the free software WinMDI, The Scripps Research Institute, La Jolla, CA). A logical gate (back-gating on FL3-CK19) combining CK19+cells and their scatter properties were used for identifying the EC population. Instrument setting, compensation and calibration were performed using 3-color calibration beads (bdbioscience [BD Biosciences], San Jose, CA).
###end p 23
###begin title 24
Cytokine secretion analysis
###end title 24
###begin p 25
Conditioned media were collected and clarified by centrifugation before predilution and sample loading in 96-well precoated plates. IFN-gamma, IL-4, IL-10, and IL-12 p40 levels were assayed using the commercially available (ELISA) kits, according to the manufacturer's instructions (Biosource International, Camarillo, CA). Absorbance was detected using an ELISA reader (Tecan Systems, Inc., San Jose, CA). Normalization for total protein was achieved between the different treatments by A280 spectrophotometric analysis (Nanodrop). Cytokine release is expressed in the text as percentage of release in comparison to untreated sister cells.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
Data are expressed as the mean+/-SD (in the text) or mean+/-SEM (in figures). Parametric ANOVA coupled with Tukey-Kramer post hoc analysis was used to detect significant difference (statistical package StatView II for PC; Abacus Concepts. Inc., San Jose, CA). A p</=0.05 was considered as statistically significant.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 138 147 138 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 295 298 295 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;2</sub>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 457 466 457 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 540 541 540 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 650 659 650 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 875 876 875 876 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 897 900 897 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-2</sub>
###xml 1008 1012 1008 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 1020 1023 1020 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 991 997 <span type="species:ncbi:9606">humans</span>
An increasing number of cuboidal cells with typical morphology of ECs migrated from the VKC conjunctival explants by 1 week of culturing (Figure 1A, left) and reached confluence by 10 days. At confluence outgrew cells were harvested and analyzed (P0) or replated for dose-response experiments (P1-2). As detected by FACS analysis, approximately 97% of gated VKC and healthy-control (P0) ECs stained positive for CK19, a defining marker of conjunctival ECs (Figure 1A, middle and right). Confocal analysis on cytospun of untouched primary (P0) VKC-ECs showed the presence of TLR4 (Cy2, middle) at either membrane or cytoplasm points, while TLR9 (cy5, Figure 1A, right) was mainly localized at the cytoplasm level (Figure 1B, merge). Particularly, a weak fluorescence for TLR9 was detected compared to those of TLR4. The in vitro studies were carried out on primary cultures (P0) and few passages (P1-2) conjunctival ECs in order to retain the in vivo VKC phenotype. As previously reported in humans, both trkANGFR and p75NTR are expressed by VKC epithelium and primary cultures of ECs [10,12].
###end p 29
###begin p 30
###xml 95 96 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 484 485 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 492 493 492 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 729 730 729 730 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 737 741 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 807 808 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 829 835 <span type="species:ncbi:9103">Turkey</span>
Characterization of primary conjunctival epithelial cells outgrew from VKC explants (VKC-ECs). A: Phase contrast microscopy (Normasky) showing VKC-ECs migrating from explants after 1 week (left, 10x optic field). The picture is representative of all VKC biopsies. A representative forward/side scatter plot of gated primary VKC-ECs (middle) and a FC-CK19 histogram demonstrating the purity of outgrew ECs (right; solid area: background staining (negative control); bold line: 97% CK19+ ECs). B: Confocal analysis specific for TLR4 and TLR9 (merge) in VKC-ECs. Control-isotype signal (data not shown) was used in channel series acquisitions, and identical acquisition settings were carried out for all images (60x oil immersion). C: TLR4/TLR9 transcript expression in untouched primary cultures of VKC-ECs (P0; p<0.01, REST-ANOVA Turkey-Kramer-coupled analysis).
###end p 30
###begin title 31
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
Molecular expression of TLR4 and TLR9 in VKC conjunctival ECs
###end title 31
###begin p 32
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 157 161 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 194 198 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 259 263 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 297 301 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 376 381 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 386 388 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H3</italic>
###xml 460 469 436 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 527 531 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 563 567 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 685 689 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 690 694 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 784 788 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 789 793 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 841 845 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 846 850 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
Spontaneous TLR4/TLR9 transcript expression was evaluated in these untouched primary (P0) VKC-ECs by relative real-time PCR. Briefly, in VKC-ECs DeltaCt for TLR4 was 9.85+/-5.34 and DeltaCt for TLR9 was 16.56+/-3.78, while in healthy-control ECs, DeltaCt for TLR4 was 10.16+/-2.57 and DeltaCt for TLR9 was 5.17+/-1.12, as detected after Ct normalization with reference genes (GAPDH and H3). Ct values are inversely proportional to gene expression. As shown in Figure 1C, the REST analysis of the single Ct values indicate that TLR4 transcript was increased while TLR9 transcript was decreased in primary VKC-ECs compared to their healthy-control counterpart (+1.23+/-2.71/-4.03+/-0.04 TLR4/TLR9, p<0.01 REST-ANOVA Tukey-Kramer-coupled analysis; ranging from -4.15+/-2.11/-2.37+/-0.26 TLR4/TLR9 for mildly active to +1.77+/-5.90/-6.47+/-2.81 TLR4/TLR9 for inflamed VKC).
###end p 32
###begin p 33
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 200 204 200 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 273 274 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 350 354 350 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 430 430 430 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
Since NGF ability to modulate TLR4/TLR9 expression was hypothesized, dose-response studies were performed with exogenous NGF over a 24-h exposure. To perform these studies, a preliminary check of trkANGFR and p75NTR protein expression was carried out in passaged VKC-ECs (P1) by confocal analysis. As depicted in Figure 2, VKC ECs expressed both trkANGFR/p75NTR, indicating VKC-ECs as well as healthy ECs are suitable for in vitroexposure to exogenous NGF.
###end p 33
###begin p 34
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
TrkANGFR/p75NTR protein expression in primary untouched VKC conjunctival epithelial cells (VKC-ECs). Confocal analysis specific for trkANGFR (middle) and p75NTR (right) in VKC-ECs. Control-isotype signal (left) was used in channel series acquisitions, and identical acquisition settings were applied for all images (60x oil immersion).
###end p 34
###begin title 35
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
Molecular expression of TLR4/TLR9 in VKC conjunctival ECs as a function of NGF exposure
###end title 35
###begin p 36
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 476 480 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 676 685 660 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 704 708 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 709 713 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 889 893 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 915 919 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 973 977 949 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1175 1179 1143 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1464 1465 1420 1421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1486 1489 1442 1445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-2</sub>
###xml 1500 1504 1456 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
In parallel experiments for few passages VKC and healthy-control ECs, different TLR4/TLR9 target gene responses were triggered as a function of short-term NGF. In VKC-ECs, the exposure to increasing NGF doses resulted in a rising modulation of TLR4/TLR9 expression, with a consistent response for TLR4 (5.40+/-0.74 at 1 ng/ml, 6.57+/-0.90 at 10 ng/ml, 9.07+/-1.17 at 100 ng/ml and 0.26+/-0.04 at 250 ng/ml NGF; p<0.01 REST-ANOVA Tukey-Kramer-coupled analysis) with respect to TLR9 (2.02+/-0.33 at 1 ng/ml, 3.01+/-0.55 at 10 ng/ml, 5.55+/-0.77 at 100 ng/ml, and 1.23+/-0.17 at 250 ng/ml NGF; p<0.01 REST-ANOVA Tukey-Kramer-coupled analysis) when compared to untreated VKC-ECs (Figure 3A). This consistent TLR4/TLR9 transcript upregulation was not monitored when VKC-ECs were incubated with NGF (100 ng/ml) in the presence of neutralizing anti-NGF antibodies (0.5 microg/ml; 1.21+/-0.39 for TLR4 and -1.47+/-0.08 for TLR9, respectively). In few passages healthy-control ECs, TLR4 expression was downregulated (2.97+/-0.51 at 1 ng/ml, -1.25+/-0.07 at 10 ng/ml, -4.18+/-0.19 at 100 ng/ml, and 0.16+/-0.05 at 250 ng/ml NGF; p<0.01 REST-ANOVA Tukey-Kramer-coupled analysis), while TLR9 expression was upregulated (3.27+/-0.54 at 1 ng/ml, 1.12+/-0.24 at 10 ng/ml, 0.85+/-0.17 at 100 ng/ml, and 1.67+/-0.31 at 250 ng/ml NGF; p<0.01 REST-ANOVA Tukey-Kramer-coupled analysis), when compared to untreated ones. No significant difference in DeltaCt occurred between primary (P0) and few passages (P1-2) VKC ECs. TLR2 expression was used as an internal control.
###end p 36
###begin p 37
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 153 156 153 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-2</sub>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 613 614 613 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 864 865 864 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1165 1166 1165 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
NGF modulates TLR4/TLR9 expression in VKC conjunctival epithelial cells (VKC-ECs). A: Relative TLR4/TLR9 transcript expression in few passages VKC-ECs (P1-2). Short-term 1-250 ng/ml NGF exposure induced a steady TLR4 and a slight TLR9 increasing response (p<0.01, REST-ANOVA Tukey-Kramer-coupled analysis). As depicted, the maximum effect was observed at 100 ng/ml NGF, while its specific pretreatment with neutralizing anti-NGF antibody resulted in a downregulation of TLR9 transcripts. Single Ct values were normalized to referring genes, and folds were calculated with respect to their untreated sister cells. B: Confocal analysis specific for TLR4 (middle) and TLR9 (right) in 100 ng/ml NGF-treated VKC-ECs. Control-isotype signal (left) was used in channel series acquisitions, and identical acquisition settings were done for all images (60x oil immersion). C: FACS showed a significant upregulation of both TLR4/TLR9 proteins (5,000 events, right). Note the absence of TLR9 signal in untreated VKC-ECs (left). TLR2 signal was used as internal control since no difference was observed in molecular analysis. Isotype-matched control antibody staining was in 101 log decade (IF=7.65; solid area). The graphs are representative of three independent experiments for each sample, which gave identical results.
###end p 37
###begin title 38
Biochemical evaluation of TLR4/TLR9 protein in VKC conjunctival ECs as a function of NGF exposure
###end title 38
###begin p 39
###xml 162 171 162 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 376 385 376 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
Confocal analysis revealed that exposure to 100 ng/ml NGF increased intra-cytoplasm expression of TLR4/TLR9 and led to partial translocation at the cell surface (Figure 3B). Whole (surface and intracellular) TLR4/TLR9 staining in VKC-ECs was carried out by FACS analysis to verify whether TLR4/TLR9 transcript modulation resulted in an altered protein expression. As shown in Figure 3C, untreated VKC-ECs showed a consistent TLR4 expression in comparison to undetectable TLR9 (left), while a consistent TLR4/TLR9 expression was assessed after 100 ng/ml NGF exposure (right).
###end p 39
###begin title 40
Biochemical evaluation of cytokine release from VKC conjunctival ECs as a function of NGF exposure
###end title 40
###begin p 41
Briefly, IFN-gamma, IL-4, IL-10 and IL-12 p40 were quantified in conditioned media from passaged VKC-ECs either untreated or NGF treated. NGF did not influence IFN-gamma, IL-12 p40, or IL-4 cytokine release in these VKC-ECs. Interestingly, NGF induced a significant decrease of IL-10 protein release in a dose-dependent fashion (% decrease: -5.67% at 1 ng/mL, -39.01% at 10 ng/ml, -59.23% at 100 ng/ml and -59.23% at 250 ng/ml NGF; p<0.01, ANOVA Tukey-Kramer post hoc) in comparison to untreated VKC-ECs (70.87+/-4.89 pg/ml).
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
This study confirmed and extended in vitro the previous observation of TLR4/TLR9 expression in VKC conjunctival epithelium [20]. Short-term NGF exposure triggered a dose-response TLR4/TLR9 transcript upregulation in cultured VKC-ECs, an effect confirmed by the related biochemical analysis. Finally, NGF exposure resulted in a decrease of IL-10 release without effects on IFN-gamma, IL-4 or IL-12 p40, as detected by the analysis of the conditioned media.
###end p 43
###begin p 44
###xml 36 40 36 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 839 843 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1007 1011 1007 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1016 1020 1016 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1086 1090 1086 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 1094 1097 1094 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1124 1128 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1129 1133 1129 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1171 1172 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
On the ocular surface, NGF (via trkANGFR/p75NTR) exerts pleiotrophic effects and contributes to the regulation of immune response and modulation of the tissue remodeling that occur in VKC [8-12,28]. Since high trkANGFR expression was detected in VKC conjunctival epithelium [11] and since NGF is impaired in VKC conjunctiva [11,12], we wondered whether exogenous NGF might contribute and/or modulate TLR4/TLR9 expression in VKC conjunctival epithelium. Primary untouched cultures of VKC-ECs showed high TLR4 and low TLR9 expression, in line with those observed in VKC conjunctival epithelium [20] and conjunctival impression cytologies [unpublished data]. Focused NGF dose-response studies in few passages VKC-ECs resulted in a steady TLR4 and a moderate TLR9 upregulation at either molecular or biochemical levels. This NGF-mediated TLR4/TLR9 upregulation appeared strictly associated with VKC phenotypes, as confirmed by the different NGF effects in healthy-control counterparts. The lower expressions of TLR4 and TLR9 at 250 ng/ml NGF strengthen suggest the contribution of both trkANGFR/p75NTR receptors in NGF-mediated TLR4/TLR9 expression, according to kd binding [9].
###end p 44
###begin p 45
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 919 922 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1059 1063 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1064 1068 1064 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1395 1397 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 1398 1400 1398 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 1416 1420 1416 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1421 1425 1421 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 1513 1515 1513 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1516 1518 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1627 1628 1627 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1629 1630 1629 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 2156 2160 2144 2148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 2325 2327 2309 2311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 2328 2330 2312 2314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 889 895 <span type="species:ncbi:9606">humans</span>
The findings of this study suggest an additional NGF contribution in VKC inflammation. As the ocular surface expresses its own (resident) microflora and is constantly exposed to foreign substances, TLRs must be highly regulated to guarantee a quick response and prevent uncontrolled inflammatory launch [29,30]. As recently observed, TLRs are significantly affected and might contribute to the onset/ongoing of allergic and autoimmune manifestations [30]. Particularly, several data encompass the role of the Gram-negative ligand TLR4 in both acute and chronic Th1/Th2 disorders and more interesting their contribution in the homeostasis [14,15,30]. However, increasing evidence supports TLR9-based immunotherapy in allergic disorders, as shown in the prevention/treatment of experimental models of allergy [31,32]. In previous studies, the NGF/TLR4 association in experimental models and humans as well as the TLR9/p75NTR association in cultured fibroblasts provide a possible link between NGF and innate immune response [21,22]. In this study, NGF-mediated TLR4/TLR9 overexpression appears extremely attractive since it would imply an increased EC sensitization to microbial patterns. Alongside pathogens/commensal bacteria, which represent common TLR activator/modulator, other factors (growth factors, cytokines and neuropeptides) might contribute to the cell-surface expression of TLRs [19,33-36]. NGF-mediated TLR4/TLR9 overexpression might favor a Th1 response according to the activated cytokine pattern [14,15]. In VKC tears and inflamed conjunctiva, several cytokines have been detected as a source of activated ECs [4,5]. Since NGF might be a product and might contribute directly or indirectly to the milieu of cytokines (IFN-gamma/IL-4/IL-12 p40/IL-10) detected in VKC, NGF-treated VKC-ECs were also investigated in terms of cytokine release. As detected in the conditioned media, NGF did not influence the release of IFN-gamma or IL-12 p40, while a decrease of IL-10 release was detected. This finding implies that NGF does not modulate Th1/Th2 balance via direct IFN-gamma or IL-12 p40 release. The NGF-mediated IL-10 decrease might sustain TLR9 overexpression since IL-10 neutralization significantly increased the deoxycytidylate-phosphate-deoxyguanylate (CpG)-induced IFN-alpha response in Peyer's patches [36,37].
###end p 45
###begin p 46
###xml 220 222 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 366 368 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 592 594 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 595 597 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 650 654 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 778 782 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 944 945 940 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 946 948 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 949 951 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 986 990 982 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1115 1119 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1239 1241 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 1194 1202 <span type="species:ncbi:9606">children</span>
An emerging paradigm indicates that commensal bacteria downregulate Th2 responses through nuclear factor-kappaB activation, while reduced exposure to microbial patterns might support a Th2 response (hygiene hypothesis) [17]. Therefore, a hypothetical regulation of microflora composition might offer the possibility to prevent and/or treat some Th2-linked diseases [18]. The recent observation that a viral infection might ameliorate both clinical signs and symptoms during active VKC as well as the observation that topical treatment with probiotics resulted in the resolution of VKC forms [38,39] support this hypothesis. In addition, NGF-mediated TLR9 upregulation might be in line with the observation that synthetic immunostimulatory sequence (CpG motif ligands) activates TLR9, resulting in a more effective response than steroids in attenuating both asthma, allergic conjunctivitis and allergic rhinitis via specific Th2 downregulation [5,39,40]. On the other hand, NGF-mediated TLR4 expression might suggest an NGF contribution in the regulation of bacterial clearance, as suggested by the observation that TLR4 expression might drive a correct bacterial clearance in airway cells from children with airway bacterial colonization [41].
###end p 46
###begin p 47
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
Cytokines, neuropeptides and growth factors might contribute to the modulation of TLR expression or be modulated by TLR-ligand activation. Recent information has noted the role of some soluble mediators (histamine), neurotransmitter (vasoactive intestinal peptide) or growth factors (epidermal growth factor receptor) in the modulation of TLR expression in different cell types [14,15,42,43]. According to the NGF pathway expression in VKC conjunctiva, exogenous NGF might contribute, either alone or in combination, to modulate innate response by counteracting TLR9 downregulation observed in VKC epithelium. This NGF-mediated TLR9 expression would allow a prompt response to specific exogenous and/or eventual synthetic ligands (probiotics/CpG-DNA). The possibility that other inflamed tissue-released factors might favor or counteract this NGF-mediated TLR9 modulation should be taken into consideration.
###end p 47
###begin p 48
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR9</italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
Overall, the finding of this study support a theoretical NGF modulation of immune/adaptive response by means of TLR4/TLR9 overexpression in VKC-ECs. The possible interaction between NGF and TLR4/TLR9 in VKC-ECs could lead to a new and higher comprehension of VKC pathology and to the development of nonconventional therapies [31,44].
###end p 48
###begin title 49
Acknowledgments
###end title 49
###begin p 50
###xml 279 287 <span type="species:ncbi:9606">patients</span>
This study was presented in part at the 2006 Association for Research in Vision and Ophthalmology meeting in Fort Lauderdale, Florida. Meeting presentation: Micera A. et al., Growth factors modulate Toll-like receptor expression in primary cultured fibroblasts obtained from VKC patients. ARVO 2006.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis.
###end article-title 52
###begin article-title 53
Allergic and immunologic disorders of the eye. Part ll: Ocular allergy.
###end article-title 53
###begin article-title 54
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis.
###end article-title 54
###begin article-title 55
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
###end article-title 55
###begin article-title 56
###xml 126 134 <span type="species:ncbi:9606">patients</span>
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
###end article-title 56
###begin article-title 57
Nerve growth factor signaling, neuroprotection, and neural repair.
###end article-title 57
###begin article-title 58
New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis.
###end article-title 58
###begin article-title 59
###xml 45 50 <span type="species:ncbi:9606">Human</span>
Nerve Growth Factor has a Modulatory Role on Human Primary Fibroblast Cultures Derived from VKC Conjunctiva.
###end article-title 59
###begin article-title 60
Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases.
###end article-title 60
###begin article-title 61
Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases.
###end article-title 61
###begin article-title 62
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells.
###end article-title 62
###begin article-title 63
Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis.
###end article-title 63
###begin article-title 64
###xml 29 34 <span type="species:ncbi:9606">human</span>
The immunomodulatory role of human conjunctival epithelial cells.
###end article-title 64
###begin article-title 65
Toll-like receptors: critical proteins linking innate and acquired immunity.
###end article-title 65
###begin article-title 66
TLR signaling pathways.
###end article-title 66
###begin article-title 67
Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
###end article-title 67
###begin article-title 68
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
###end article-title 68
###begin article-title 69
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
###end article-title 69
###begin article-title 70
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.
###end article-title 70
###begin article-title 71
Expression of Toll-like receptors in healthy and allergic conjunctiva.
###end article-title 71
###begin article-title 72
###xml 66 71 <span type="species:ncbi:9606">human</span>
Nerve growth factor promotes TLR4 signaling-induced maturation of human dendritic cells in vitro through inducible p75NTR 1.
###end article-title 72
###begin article-title 73
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-kappaB pathways.
###end article-title 73
###begin article-title 74
###xml 24 29 <span type="species:ncbi:9606">human</span>
In vitro propagation of human ocular surface epithelial cells for transplantation.
###end article-title 74
###begin article-title 75
###xml 54 59 <span type="species:ncbi:9606">human</span>
Culture and characterisation of epithelial cells from human pterygia.
###end article-title 75
###begin article-title 76
###xml 82 87 <span type="species:ncbi:9606">human</span>
Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva.
###end article-title 76
###begin article-title 77
Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
###end article-title 77
###begin article-title 78
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.
###end article-title 78
###begin article-title 79
Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate.
###end article-title 79
###begin article-title 80
Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA.
###end article-title 80
###begin article-title 81
Toll-like receptor ligands and atopy: a coin with at least two sides.
###end article-title 81
###begin article-title 82
TLR9-based immunotherapy for allergic disease.
###end article-title 82
###begin article-title 83
DNA-based immunotherapeutics for the treatment of allergic disease.
###end article-title 83
###begin article-title 84
###xml 102 107 <span type="species:ncbi:9606">human</span>
Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin.
###end article-title 84
###begin article-title 85
Regulation of TLR expression, a new perspective for the role of VIP in immunity.
###end article-title 85
###begin article-title 86
Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER.
###end article-title 86
###begin article-title 87
The role of neuromediators in ocular allergy.
###end article-title 87
###begin article-title 88
###xml 40 45 <span type="species:ncbi:9940">sheep</span>
A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses.
###end article-title 88
###begin article-title 89
Allergy and infections: long-term improvement of vernal keratoconjunctivitis following viral conjunctivitis.
###end article-title 89
###begin article-title 90
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis.
###end article-title 90
###begin article-title 91
Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
###end article-title 91
###begin article-title 92
Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases.
###end article-title 92
###begin article-title 93
###xml 113 121 <span type="species:ncbi:9606">children</span>
Reduced toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonization in children.
###end article-title 93
###begin article-title 94
VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts.
###end article-title 94
###begin article-title 95
###xml 88 110 <span type="species:ncbi:727">Haemophilus influenzae</span>
Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway.
###end article-title 95
###begin article-title 96
Prevention of Acute Allergic Conjunctivitis and Late-Phase Inflammation with Immunostimulatory DNA Sequences.
###end article-title 96

